Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALKS | AMGN | GILD | VRTX | BIIB |
| Company | Alkermes Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 23.84 | 266.83 | 67.80 | 396.88 | 196.20 |
| High | 24.10 | 267.51 | 67.89 | 398.49 | 197.73 |
| Low | 23.65 | 263.81 | 67.18 | 392.81 | 194.94 |
| Last | 23.77 | 265.64 | 67.31 | 394.17 | 195.15 |
| Change | -0.25 | +0.13 | -0.44 | -3.19 | -1.65 |
| % Change | -1.04% | +0.05% | -0.65% | -0.80% | -0.84% |
| Volume | 1,579,900 | 2,017,500 | 4,974,900 | 695,300 | 871,900 |
| 20-Day Average Volume | 1,804,920 | 2,269,115 | 6,427,060 | 900,790 | 1,092,630 |
| Previous Close | 24.02 | 265.51 | 67.75 | 397.36 | 196.80 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.32 | 273.86 | 70.93 | 408.62 | 209.06 |
| 20-Day Raw Stochastic | 2.76% | 7.39% | 1.83% | 4.75% | 0.78% |
| 20-Day Relative Strength | 32.41% | 38.83% | 30.61% | 37.13% | 29.58% |
| Weighted Alpha | -23.26 | +5.85 | -23.45 | +15.90 | -36.64 |
| Today's Opinion | 56% Sell | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 72% Buy | 8% Sell | 72% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.07% since 04/09/24 | -1.75% since 04/09/24 | -3.76% since 04/09/24 | -2.55% since 04/09/24 | -5.51% since 04/09/24 |
| Low | 23.65 on 04/16/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 | 194.94 on 04/16/24 |
| High | 26.42 on 04/10/24 | 273.00 on 04/11/24 | 69.76 on 04/10/24 | 404.69 on 04/11/24 | 205.24 on 04/12/24 |
| 1-Month | |||||
| %Chg | -17.32% since 03/15/24 | -1.20% since 03/15/24 | -8.66% since 03/15/24 | -3.32% since 03/15/24 | -11.02% since 03/15/24 |
| Low | 23.65 on 04/16/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 | 194.94 on 04/16/24 |
| High | 28.79 on 03/18/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | -14.37% since 01/16/24 | -12.47% since 01/16/24 | -21.72% since 01/16/24 | -9.90% since 01/16/24 | -20.73% since 01/16/24 |
| Low | 23.65 on 04/16/24 | 263.81 on 04/16/24 | 67.18 on 04/16/24 | 392.81 on 04/16/24 | 194.94 on 04/16/24 |
| High | 32.88 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | -15.20% since 10/16/23 | -7.40% since 10/16/23 | -15.01% since 10/16/23 | +5.39% since 10/16/23 | -27.17% since 10/16/23 |
| Low | 22.01 on 10/25/23 | 249.70 on 10/31/23 | 67.18 on 04/16/24 | 341.90 on 11/16/23 | 194.94 on 04/16/24 |
| High | 32.88 on 02/16/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 269.43 on 10/17/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,063,800 | 142,291,856 | 84,353,968 | 102,701,272 | 28,607,044 |
| Shares Outstanding, K | 169,184 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 1,663,410,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | 355,760,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 377,480,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | 112,780,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 0.56 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.48 on 02/15/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 04/24/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 21.80 | 14.33 | 10.13 | 29.51 | 13.45 |